Thomas K Equels bought $1,292 of AIM
CEO & President at AIM ImmunoTech Inc.. 5,900 shares at an average of $0.22, traded Sep 14, 2026, filed Sep 15, 2026.
Score components
- +25RoleCEO
- 0Trade size$1k at market
- +3Relative to holdingsHoldings up 9%
- +18Price context0% above the 52-week low; 92% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-042754, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | POpen-market purchase Common Stock | +5,900 | $0.22 | $1,292 | 69,822 | 28 d ago |
Related signals
Other insiders at AIM ImmunoTech Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 54Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $4,992 24,000 shares | +23% | |
| 51Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $2,310 11,000 shares | +12% | |
| 54Moderate | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $4,862 22,000 shares | +32% | |
| 33Weak | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $824 107 shares | +0% | |
| 33Weak | AIMbuy AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $896 103 shares | +0% | |
| 65Notable | AIM ImmunoTech Inc. | Ted D Kellner director | $50k 1,968,504 shares | first purchase | |
| 80Strong | AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $50k 1,968,504 shares | +104% | |
| 58Moderate | AIM ImmunoTech Inc. | William M Mitchell director | $5,000 196,851 shares | +61% | |
| 63Notable | AIM ImmunoTech Inc. | Thomas K Equels CEO & President | $2,583 41,000 shares | +2% | |
| 48Moderate | AIM ImmunoTech Inc. | Peter W Rodino III COO, Secretary, Gen. Counsel | $44 500 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.